slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6.670 KRW | -0,45% | +3,73% | -5,12% |
2023 | Optipharm.CO.,LTD rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2023 | CI |
Omzet 2022 | 16,01 mld. 11,64 mln. 10,89 mln. | Omzet 2023 | 17,37 mld. 12,63 mln. 11,81 mln. | Marktkapitalisatie | 103 mld. 74,98 mln. 70,13 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -2,04 mld. -1,49 mln. -1,39 mln. | Nettowinst (verlies) 2023 | -2,44 mld. -1,77 mln. -1,66 mln. | EV/omzet 2022 | 5,87 x |
Nettoliquiditeiten 2022 | 8,9 mld. 6,47 mln. 6,05 mln. | Nettoliquiditeiten 2023 | 5,6 mld. 4,07 mln. 3,81 mln. | EV/omzet 2023 | 5,61 x |
K/w-verhouding 2022 |
-50,2
x | K/w-verhouding 2023 |
-42,3
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 58,98% |
1 dag | -0,45% | ||
1 week | +3,73% | ||
Lopende maand | -5,52% | ||
1 maand | -5,66% | ||
3 maanden | -2,91% | ||
6 maanden | -4,71% | ||
Lopend jaar | -5,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Beom-Gu Han
BRD | Director/Board Member | 55 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hyun-Il Kim
CEO | Chief Executive Officer | 52 | - |
Ki-Myung Choi
CTO | Chief Tech/Sci/R&D Officer | 52 | - |
Young-Ho Kim
BRD | Director/Board Member | 47 | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 6.670 | -0,45% | 7 497 |
25-04-24 | 6.700 | +0,90% | 8 879 |
24-04-24 | 6.640 | +2,47% | 10 105 |
23-04-24 | 6.480 | +0,78% | 10 844 |
22-04-24 | 6.430 | 0,00% | 6 987 |
slotkoers Korea S.E., 26 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-5,12% | 71,56 mln. | |
-19,73% | 70,08 mld. | |
-11,01% | 6,43 mld. | |
+15,88% | 3,52 mld. | |
-2,92% | 3,11 mld. | |
-0,68% | 1,38 mld. | |
-17,27% | 1,37 mld. | |
-2,73% | 1,24 mld. | |
-14,67% | 1,13 mld. | |
-5,37% | 1,02 mld. |